Log In
BCIQ
Print this Print this
 

CT100

  Manage Alerts
Collapse Summary General Information
Company Celleron Therapeutics Ltd.
DescriptionSoluble prodrug of quercetin
Molecular Target Undisclosed
Mechanism of ActionKinase inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today